Valuation : Stryker Corporation

Market Cap 122B 105B 98.79B 90B 169B 11,554B 170B 1,168B 455B 5,878B 457B 447B 19,489B P/E 2026 *
24.7x
P/E 2027 * 21.5x
Enterprise Value 131B 113B 106B 96.74B 182B 12,420B 183B 1,255B 489B 6,318B 491B 481B 20,950B EV / Sales 2026 *
4.79x
EV / Sales 2027 * 4.3x
Free-Float
94.9%
Yield 2026 *
1.13%
Yield 2027 * 1.21%
1 day+1.18%
1 week-0.91%
Current month+1.10%
1 month+0.96%
3 months+8.40%
6 months-15.16%
Current year-7.17%
1 week 316.73
Extreme 316.73
342
1 month 316.73
Extreme 316.73
357
Current year 281.04
Extreme 281.04
389.55
1 year 281.04
Extreme 281.04
396.86
3 years 250.79
Extreme 250.79
406.7
5 years 191.18
Extreme 191.18
406.7
10 years 127.68
Extreme 127.6758
406.7
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
President 49 2025-12-31
Director of Finance/CFO 50 2025-03-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%-0.91% - - 124B
-1.98%-3.99%-18.91%+11.58% 124B
+0.71%+0.19%-22.86%+0.52% 12.11B
-1.59%-2.59%+84.41%+135.95% 10.59B
+1.11%+0.52%-52.34%-70.07% 4.16B
-1.07%-9.48%-25.73%+36.87% 2.52B
+0.53%-1.31% - - 2B
-2.33%+0.74%-34.34%-74.24% 1.82B
-0.07%-2.79%-19.18%-23.16% 1.6B
Average -0.39%-2.61%-12.71%+2.49% 19.87B
Weighted average by Cap. -0.38%-3.52%-13.42%+16.01%

Financials

2026 *2027 *
Net sales 27.3B 23.54B 22.15B 20.18B 37.94B 2,590B 38.15B 262B 102B 1,318B 102B 100B 4,369B 29.67B 25.6B 24.08B 21.94B 41.25B 2,816B 41.47B 285B 111B 1,433B 111B 109B 4,750B
Net income 4.94B 4.26B 4.01B 3.65B 6.87B 469B 6.91B 47.4B 18.45B 239B 18.55B 18.15B 791B 5.75B 4.96B 4.66B 4.25B 7.99B 545B 8.03B 55.12B 21.45B 277B 21.57B 21.11B 920B
Net Debt 9.13B 7.87B 7.4B 6.75B 12.68B 866B 12.75B 87.53B 34.07B 441B 34.26B 33.52B 1,461B 5.89B 5.08B 4.78B 4.35B 8.19B 559B 8.23B 56.48B 21.98B 284B 22.11B 21.63B 943B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26-09-01 US$322.29 -0.78% 137
26-08-31 US$324.82 -1.36% 140
26-08-28 US$329.30 +1.22% 2,678
26-08-27 US$325.32 -1.92% 518
26-08-26 US$331.69 +0.08% 219
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
317.40USD
Average target price
382.72USD
Spread / Average Target
+20.58%

Quarterly revenue - Rate of surprise